This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jun 18;125(25):3828-9.

doi: 10.1182/blood-2015-04-639419.

Beyond the first glance: anthracyclines in AML

Hugo F Fernandez¹

Affiliations

PMID: 26089377
DOI: 10.1182/blood-2015-04-639419

Free article

Comment

Beyond the first glance: anthracyclines in AML

Hugo F Fernandez. Blood. 2015.

Free article

. 2015 Jun 18;125(25):3828-9.

doi: 10.1182/blood-2015-04-639419.

Author

Hugo F Fernandez¹

Affiliation

¹ MOFFITT CANCER CENTER AND RESEARCH INSTITUTE.

PMID: 26089377
DOI: 10.1182/blood-2015-04-639419

No abstract available

PubMed Disclaimer

Comment on

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.
Burnett AK, Russell NH, Hills RK, Kell J, Cavenagh J, Kjeldsen L, McMullin MF, Cahalin P, Dennis M, Friis L, Thomas IF, Milligan D, Clark RE; UK NCRI AML Study Group. Burnett AK, et al. Blood. 2015 Jun 18;125(25):3878-85. doi: 10.1182/blood-2015-01-623447. Epub 2015 Apr 1. Blood. 2015. PMID: 25833957 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information